Stéphane Girault

Predictive Features of Severe Acquired ADAMTS13 Deficiency in Idiopathic Thrombotic Microangiopathies: The French TMA Reference Center Experience

Paul Coppo, Michaël Schwarzinger, M. Buffet et al. · PLoS ONE · 2010 · 415 citations · Full text

Medicine, Hematology, Internal Medicine +9

Rituximab and dose-dense chemotherapy for adults with Burkitt's lymphoma: a randomised, controlled, open-label, phase 3 trial

Vincent Ribrag, Serge Koscielny, Jacques Bosq et al. · The Lancet · 2016 · 187 citations

Medicine, Oncology, Pharmacotherapy +9

Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis (MOMENTUM): results from an international, double-blind, randomised, controlled, phase 3 study

Srđan Verstovšek, Aaron T. Gerds, Alessandro M. Vannucchi et al. · The Lancet · 2023 · 185 citations

Medicine, Hematology, Pharmacology +9

Preemptive rituximab prevents long-term relapses in immune-mediated thrombotic thrombocytopenic purpura

Matthieu Jestin, Y. Benhamou, An‐Sofie Schelpe et al. · Blood · 2018 · 160 citations · Full text

Medicine, Hematology, Immunology +13

Tumour lysis syndrome and acute kidney injury in high‐risk haematology patients in the rasburicase era. A prospective multicentre study from the Groupe de Recherche en <scp>R</scp>éanimation Respiratoire et <scp>O</scp>nco‐<scp>H</scp>ématologique

Michaël Darmon, François Vincent, Laurent Camous et al. · British Journal of Haematology · 2013 · 109 citations

Medicine, Hematology, Oncology +14